Nab-PTX is associated with increased uptake by utilising the endogenous albumin pathways of gp60- and Cav-1-mediated endovascular transcytosis and binding between albumin and SPARC, which enables the drug to more thoroughly permeate the tumour [18]. Here, SPARC is linked to neoplasm.